A new trading day began on Tuesday, with Integra Lifesciences Holdings Corp (NASDAQ: IART) stock price up 5.84% from the previous day of trading, before settling in for the closing price of $12.32. IART’s price has ranged from $11.60 to $32.66 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 1.20%. Meanwhile, its annual earnings per share averaged -11.74%. With a float of $65.57 million, this company’s outstanding shares have now reached $77.71 million.
Let’s determine the extent of company efficiency that accounts for 4396 employees. In terms of profitability, gross margin is 65.53%, operating margin of 2.91%, and the pretax margin is -2.65%.
Integra Lifesciences Holdings Corp (IART) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Integra Lifesciences Holdings Corp is 15.62%, while institutional ownership is 95.01%. The most recent insider transaction that took place on Dec 03 ’24, was worth 100,102. In this transaction EVP, Chief Legal Officer & Sec of this company sold 4,070 shares at a rate of $24.59, taking the stock ownership to the 59,511 shares. Before that another transaction happened on Dec 03 ’24, when Company’s Officer proposed sale 4,070 for $24.59, making the entire transaction worth $100,102.
Integra Lifesciences Holdings Corp (IART) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.58 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -11.74% per share during the next fiscal year.
Integra Lifesciences Holdings Corp (NASDAQ: IART) Trading Performance Indicators
Here are Integra Lifesciences Holdings Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.72. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.62.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.38, a number that is poised to hit 0.44 in the next quarter and is forecasted to reach 2.48 in one year’s time.
Technical Analysis of Integra Lifesciences Holdings Corp (IART)
Looking closely at Integra Lifesciences Holdings Corp (NASDAQ: IART), its last 5-days average volume was 1.03 million, which is a jump from its year-to-date volume of 0.88 million. As of the previous 9 days, the stock’s Stochastic %D was 45.60%. Additionally, its Average True Range was 0.90.
During the past 100 days, Integra Lifesciences Holdings Corp’s (IART) raw stochastic average was set at 9.27%, which indicates a significant decrease from 65.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.32% in the past 14 days, which was lower than the 67.19% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $16.14, while its 200-day Moving Average is $20.45. However, in the short run, Integra Lifesciences Holdings Corp’s stock first resistance to watch stands at $13.53. Second resistance stands at $14.02. The third major resistance level sits at $14.83. If the price goes on to break the first support level at $12.22, it is likely to go to the next support level at $11.41. Now, if the price goes above the second support level, the third support stands at $10.92.
Integra Lifesciences Holdings Corp (NASDAQ: IART) Key Stats
With a market capitalization of 1.01 billion, the company has a total of 77,712K Shares Outstanding. Currently, annual sales are 1,611 M while annual income is -6,940 K. The company’s previous quarter sales were 382,650 K while its latest quarter income was -25,290 K.
